Amplatzer Muscular VSD (MuVSD) Occluder
Device
Abbott Laboratories
Total Payments
$119,480
Transactions
91
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $119,480 | 91 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $119,480 | 91 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA) | Abbott Laboratories | $72,397 | 0 |
| The AMPLATZER Post-Infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study | Abbott Laboratories | $47,083 | 0 |
Top Doctors Receiving Payments for Amplatzer Muscular VSD (MuVSD) Occluder
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Minneapolis, MN | $119,480 | 91 |
Ad
Manufacturing Companies
- Abbott Laboratories $119,480
Product Information
- Type Device
- Total Payments $119,480
- Total Doctors 0
- Transactions 91
About Amplatzer Muscular VSD (MuVSD) Occluder
Amplatzer Muscular VSD (MuVSD) Occluder is a device associated with $119,480 in payments to 0 healthcare providers, recorded across 91 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $119,480 was paid across 91 transactions to 0 doctors.
The most common payment nature for Amplatzer Muscular VSD (MuVSD) Occluder is "Unspecified" ($119,480, 100.0% of total).
Amplatzer Muscular VSD (MuVSD) Occluder is associated with 2 research studies, including "Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA)" ($72,397).